Cargando…

Imaging genetic association analysis of triple-negative breast cancer based on the integration of prior sample information

Triple-negative breast cancer (TNBC) is one of the more aggressive subtypes of breast cancer. The prognosis of TNBC patients remains low. Therefore, there is still a need to continue identifying novel biomarkers to improve the prognosis and treatment of TNBC patients. Research in recent years has sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Shipeng, Xie, Juan, Mo, Jianlan, Pan, You, Huang, Rong, Huang, Qinghua, Feng, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992804/ https://www.ncbi.nlm.nih.gov/pubmed/36911413 http://dx.doi.org/10.3389/fgene.2023.1090847

Ejemplares similares

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

Integration of RNA molecules data with prior-knowledge driven Joint Deep Semi-Negative Matrix Factorization for heart failure study
por: Ma, Zhihui, et al.
Publicado: (2022)

Prognosis Prediction Through an Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Data in Triple-Negative Breast Cancer
por: Wang, Xiangru, et al.
Publicado: (2022)

Erratum: Integration of RNA molecules data with prior-knowledge driven Joint Deep Semi-Negative Matrix Factorization for heart failure study
por: Frontiers Production Office,
Publicado: (2022)

Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer
por: Huang, Qinghua, et al.
Publicado: (2023)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
por: Hu, Shaojun, et al.
Publicado: (2021)

DECtp: Calling Differential Gene Expression Between Cancer and Normal Samples by Integrating Tumor Purity Information
por: Zhang, Weiwei, et al.
Publicado: (2018)

Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
por: G., Vigneshwaran, et al.
Publicado: (2022)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

MYBL2 alternative splicing-related genetic variants reduce the risk of triple-negative breast cancer in the Chinese population
por: Chen, Xinyu, et al.
Publicado: (2023)

Identification of Five Cytotoxicity-Related Genes Involved in the Progression of Triple-Negative Breast Cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
por: Wang, Shanshan, et al.
Publicado: (2021)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene
por: Niyomnaitham, Suvimol, et al.
Publicado: (2019)

Characterization of Pyroptosis-Related Subtypes via RNA-Seq and ScRNA-Seq to Predict Chemo-Immunotherapy Response in Triple-Negative Breast Cancer
por: Li, Chenlu, et al.
Publicado: (2022)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
por: Tan, Qiaorui, et al.
Publicado: (2023)

Identification of Triple-Negative Breast Cancer Genes and a Novel High-Risk Breast Cancer Prediction Model Development Based on PPI Data and Support Vector Machines
por: Li, Ming, et al.
Publicado: (2019)

Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications
por: Liu, Shenting, et al.
Publicado: (2023)

lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network
por: Liu, Zijian, et al.
Publicado: (2019)

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Li, Shujun, et al.
Publicado: (2020)

Matrix Metalloproteinases in Relation to Bone Mineral Density: A Two-Sample Mendelian Randomization Study
por: Lv, Xin, et al.
Publicado: (2021)

Injectable thermo-sensitive hydrogel loaded hollow copper sulfide nanoparticles for ROS burst in TME and effective tumor treatment
por: Ning, Shipeng, et al.
Publicado: (2023)

Accurate Prediction of ncRNA-Protein Interactions From the Integration of Sequence and Evolutionary Information
por: Zhan, Zhao-Hui, et al.
Publicado: (2018)

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
por: Lv, Yufei, et al.
Publicado: (2021)

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
por: Wang, Nan, et al.
Publicado: (2021)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022)

Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer
por: Zhu, Baoxi, et al.
Publicado: (2022)

BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
por: Katheeja, Muhseena N., et al.
Publicado: (2023)

Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential
por: Wilson, Brooke E., et al.
Publicado: (2023)

Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer
por: Shi, Wensheng, et al.
Publicado: (2023)

Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer
por: Zhao, Kankan, et al.
Publicado: (2023)

The role of prior probability in forensic assessments
por: Thompson, William C., et al.
Publicado: (2013)

Integration of Count Difference and Curve Similarity in Negative Regulatory Element Detection
por: He, Na, et al.
Publicado: (2022)

An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer
por: Hicks, Chindo, et al.
Publicado: (2013)

Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022)

Non-Lethal Sampling Supports Integrative Movement Research in Freshwater Fish
por: Thorstensen, Matt J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_230p2n0sn6cfg576ke4mlveots